
- UCAS course code
- B230
- UCAS institution code
- M20
Course unit details:
The Medicine (Year 2)
Unit code | PHAR20100 |
---|---|
Credit rating | 20 |
Unit level | Level 2 |
Teaching period(s) | Full year |
Offered by | Pharmacy |
Available as a free choice unit? | No |
Pre/co-requisites
Unit title | Unit code | Requirement type | Description |
---|---|---|---|
The Medicine (Year 1) | PHAR10100 | Pre-Requisite | Compulsory |
The Pharmacist (Year 1) | PHAR10200 | Pre-Requisite | Compulsory |
The Patient (Year 1): Introduction to Human Biology | PHAR10300 | Pre-Requisite | Compulsory |
The Pharmacist (Year 2): Law and Professional Practice | PHAR20200 | Co-Requisite | Compulsory |
The Patient (Year 2): Pathology, Pharmacology & Therapeutics 1 | PHAR20300 | Co-Requisite | Compulsory |
The Public (Year 2): Infectious Disease & Prophylaxis/Treatment in Public Health | PHAR20400 | Co-Requisite | Compulsory |
Integrated Professional Practice (Part 1) | PHAR10500 | Pre-Requisite | Compulsory |
Yr 2 Integrated Prof Practice | PHAR20500 | Co-Requisite | Compulsory |
A-level chemistry will be helpful.
Aims
This module will provide essential knowledge for understanding the basic processes involved in the development of medicines. The course will follow a path from selecting a drug target through to manufacture of safe and effective formulations.
Learning outcomes
At the end of the course student should know:
- The basis of Drug-Target interactions and mechanism of drug action.
- How drugs can be discovered, designed and optimized.
- The basic techniques used in the formulation and manufacture of dosage forms.
- The influence of formulation on dosage form design and the bioavailability of drugs.
- The principles and practice of pharmaceutical analysis and the need to assure the quality of medicines and ancillary products.
Assessment methods
Semester 1
Consolidated examination: (25% contribution to the unit mark).
Theoretical practical exam: (10% contribution to the unit mark).
Practical lab exam (from Sem 1) (10% contribution to the unit mark).
Summative assessment: (5% contribution to the unit mark)
Semester 2
Consolidated examination: (25% contribution to the unit mark).
Practical report (5%) case study exam (15%): (20% contribution to the unit mark).
Summative assessment: (5% contribution to the unit mark)
Notes
The consolidated exams will contain questions from all three units (The Medicine, The Public and The Patient) contributing equally. Students must achieve a minimum of 40% over both semesters in the Medicine sections of the consolidated exam to pass.
Three component marks will be reported to the Examination Board as below. In order to pass this module you will need at least 40% in each of the following components:
Component 1: Semester 1 and semester 2 consolidated exams contribute 50% to the overall mark for the unit. Exam marks refers to marks received for “The Medicine” part of the consolidated exam. Students must achieve a minimum of 40% over both semesters in the Medicine sections of the consolidated exam.
Component 2: Marks for practical exam, practical course work and case study exam will be combined from both semesters to generate a single component mark which contributes 50% of the overall mark for this unit.
Component Percentage Equivalent credits
Consolidated exams 50% 10
Coursework 50% 10
Feedback methods
Online, tutorials, and during practical + case study sessions.
Recommended reading
Pharmaceutical Analysis, D.G. Watson, Churchill Livingstone (see link above). Pages 1-25 ,90-114, 115-135, 165- 194, 204-248, 265-298, 301-395, 358-375, 398-414.
Aulton’s Pharmaceutics: The design and manufacture of medicines. 3rd Edition. Ed. Aulton, Churchill Livingstone (2007). Pages 4-14, 99-107 , 351-254, 266-303, 358-359, 399-403, 483-499, 565-597, 637-638, 650-665
Cal Packages: http://www.collegeofpharmacy.com/
‘Clarkes analysis of Drugs and Poisons,’ London Pharmaceutical Press. Electronic Version can be found through ‘Medicines’ Complete’ which is accessed through the John Rylands e-database collection. Methodology & Analytical Techniques section Chapters 11, 21, 32,33,36,37,38,39,40
British Pharmacopoeia
https://www.pharmacopoeia.com/bp-2015?date=2015-01-01
https://www.medicinescomplete.com/mc/
Organic Spectroscopic Analysis," R.J. Anderson, D.J. Bendell and P.W. Groundwater, Cambridge, Royal Society of Chemistry, 2004.
Spectroscopic Methods in Organic Chemistry. D.H. Williams and I. Flemming, London, McGraw-Hill, 1995, 5th edition.
Essentials of Pharmaceutical Chemistry” (2nd ed) D. Cairns, Pharmaceutical Press, London,
2003. E-book is currently available (see link below):
http://lib.myilibrary.com/Browse/Open.asp?ID=179402
Physio-chemical Principles of Pharmacy, Florence & Attwood, 3rd Ed. Macmillian, 1997. The 4th ed. (2005) is available as E book:
http://lib.myilibrary.com/Browse/Open.asp?ID=113012
Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007, ‘The Orange Guide.’ Author MHRA, Published HMSO.
Study hours
Scheduled activity hours | |
---|---|
eAssessment | 8 |
Lectures | 55 |
Practical classes & workshops | 24 |
Tutorials | 12 |
Independent study hours | |
---|---|
Independent study | 110 |
Teaching staff
Staff member | Role |
---|---|
Harmesh Aojula | Unit coordinator |
Alain Pluen | Unit coordinator |